Abstract
Egg donation has always been a relatively expensive form of assisted reproduction. This is partly due to the obvious fact that in most cases, the donor receives financial compensation for the performance of her service, as well as the extra costs associated with screening the donor prior to her acceptance into the program. However, the discrepancies presently seen in cost between conventional IVF and donor egg IVF were not always so great. For instance, in 1990 patients were typically spending approximately $5,000–7,000 with medications for a cycle of in vitro fertilization, whereas egg donation averaged around $9,000–10,000. In 2012, including the cost of drugs, IVF in most American centers costs around $10,000, whereas a donor egg cycle commonly runs $25,000 or more per attempt.
Egg donation has become increasingly expensive due to several factors related to the egg donor portion of the treatment cycle and not to the process of IVF itself. In addition to normal medical services that must be paid for by the recipients, inflated donor compensation and state and federal regulatory requirements have steadily and substantially increased the cost of doing the business of egg donation over the last 20 years.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Glujovsky D, Fiszbajn G, Lipowicz R, Lavolpe M, Sueldo C. Practice of sharing donor oocytes among several recipients. Fertil Steril. 2006;86(6):1786–1788.
Henne MB, Bundorf MK. Insurance mandates and trends in infertility treatments. Fertil Steril. 2008;89(1):66–73.
Levens ED, Levy MJ. Ethical application of shared risk programs in assisted reproductive technology. Fertil Steril. 2011;95(7):2198–9.
Ethics Committee of the American Society for Reproductive Medicine. Shared-risk or refund programs in assisted reproduction. Fertil Steril. 2004;82 Suppl 1:S249–50.
Heng BC. Egg sharing in return for subsidized fertility treatment–ethical challenges and pitfalls. J Assist Reprod Genet. 2008;25(4):159–61.
Gorrill MJ, et al. Oocyte donor screening: the selection process and cost analysis. Fertil Steril. 2001;75(2):400–4.
Baker VL, et al. Economic cost for implementation of the U.S. Food and Drug Administration’s Code of Federal Regulations Title 21, Part 1271 in an egg donor program. Fertil Steril. 2008;90(3):537–45.
Covington SN, Gibbons WE. Society for assisted reproductive, what is happening to the price of eggs? Fertil Steril. 2007;87(5):1001–4.
Ethics Committee Of The American Society For Reproductive Medicine. Financial compensation of oocyte donors. Fertil Steril. 2007;88(2):305–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
McGrath, A.J., Sauer, M.V. (2013). The Finances of Egg Donation. In: Sauer, M. (eds) Principles of Oocyte and Embryo Donation. Springer, London. https://doi.org/10.1007/978-1-4471-2392-7_18
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2392-7_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2391-0
Online ISBN: 978-1-4471-2392-7
eBook Packages: MedicineMedicine (R0)